BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32396137)

  • 1. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
    Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
    Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
    Loh TP; Horvath AR; Wang CB; Koch D; Adeli K; Mancini N; Ferrari M; Hawkins R; Sethi S; Lippi G;
    Clin Chem Lab Med; 2020 Aug; 58(9):1441-1449. PubMed ID: 32549122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.
    Misra V; Agrawal R; Kumar H; Kar A; Kini U; Poojary A; Chakrabarti I; Rai S; Singhal A; Shankar SV; Iyengar JN
    Indian J Pathol Microbiol; 2020; 63(3):350-357. PubMed ID: 32769321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
    Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
    Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey.
    Loh TP; Horvath AR; Wang CB; Koch D; Lippi G; Mancini N; Ferrari M; Hawkins R; Sethi S; Adeli K;
    Clin Chem Lab Med; 2020 Aug; 58(9):1433-1440. PubMed ID: 32549123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID-19 pandemic: implications for the cytology laboratory.
    Pambuccian SE
    J Am Soc Cytopathol; 2020; 9(3):202-211. PubMed ID: 32284276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.
    Bohn MK; Lippi G; Horvath A; Sethi S; Koch D; Ferrari M; Wang CB; Mancini N; Steele S; Adeli K
    Clin Chem Lab Med; 2020 Jun; 58(7):1037-1052. PubMed ID: 32459192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory work safety rules and guidelines during COVID-19 pandemic in Polish clinical laboratories - do our laboratories work according to a recent IFCC Taskforce Recommendations?
    Małecka M; Ogrodzińska K; Salczyńska G; Ciepiela O
    Clin Chem Lab Med; 2020 Sep; 58(10):e205-e208. PubMed ID: 32673282
    [No Abstract]   [Full Text] [Related]  

  • 9. Occupational health responses to COVID-19: What lessons can we learn from SARS?
    Koh D; Goh HP
    J Occup Health; 2020 Jan; 62(1):e12128. PubMed ID: 32515882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
    Wang K; Zhu X; Xu J
    Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disinfection in histopathology.
    Henwood AF
    J Histotechnol; 2020 Jun; 43(2):102-104. PubMed ID: 32116147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.
    Mourya DT; Sapkal G; Yadav PD; M Belani SK; Shete A; Gupta N
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):172-176. PubMed ID: 32242878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection.
    Bohn MK; Mancini N; Loh TP; Wang CB; Grimmler M; Gramegna M; Yuen KY; Mueller R; Koch D; Sethi S; Rawlinson WD; Clementi M; Erasmus R; Leportier M; Kwon GC; Menezes ME; Patru MM; Singh K; Ferrari M; Najjar O; Horvath AR; Adeli K; Lippi G
    Clin Chem Lab Med; 2020 Oct; 58(12):1993-2000. PubMed ID: 33027042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
    Lippi G; Plebani M
    Clin Chem Lab Med; 2020 Jun; 58(7):1063-1069. PubMed ID: 32191623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposable customized aerosol containment chamber for oral cancer biopsy: A novel technique during COVID-19 pandemic.
    Sharma SS; Singh DK; Yadav AK; Swain J; Kumar S; Jain DK; Prakash P
    J Surg Oncol; 2020 Aug; 122(2):120-121. PubMed ID: 32394482
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
    Hussain Gardezi SA; Ikram A
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.
    Chen CC; Chi CY
    Cancer Cytopathol; 2020 May; 128(5):309-316. PubMed ID: 32259402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparedness and Lessons Learned from the Novel Coronavirus Disease.
    Gudi SK; Tiwari KK
    Int J Occup Environ Med; 2020 Apr; 11(2):108-112. PubMed ID: 32218558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating telemedicine as part of COVID-19 outbreak response systems.
    Rockwell KL; Gilroy AS
    Am J Manag Care; 2020 Apr; 26(4):147-148. PubMed ID: 32270980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.